NCT03732248View on ClinicalTrials.gov

Altering Memories That Increase Risk of Relapse in Alcohol Use Disorders

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

July 12, 2018

Primary Completion Date

December 20, 2019

Study Completion Date

January 20, 2020

Conditions
Alcohol Use DisorderAlcohol Dependence
Interventions
DRUG

Rapamycin

Immunosuppressive drug

DRUG

Placebo

Inert drug

Trial Locations (1)

29425

Medical University of South Carolina, Charleston

All Listed Sponsors
lead

Medical University of South Carolina

OTHER

NCT03732248 - Altering Memories That Increase Risk of Relapse in Alcohol Use Disorders | Biotech Hunter | Biotech Hunter